Journaliste

Journaliste

filtrer par
SANTE DE LA FEMME
ENDOCRINOLOGIE
Thérapie cellulaire
CORPORATE
REGLEMENTAIRE

Mars 2017

14

HRA Pharma Strengthens Board with Experienced Industry Experts

HRA Pharma Announces CEO Transition to Position Company for the Next Phase of Growth

Juillet 2016

12

HRA Pharma Announces CEO Transition to Position Company for the Next Phase of Growth

Mars 2016

08

A frisky continent: European women’s attitudes to sex and emergency contraception revealed!

Février 2016

19

HRA Pharma Wraps up Landmark 2015 and Announces Investment by Astorg and its co-investor Goldman Sachs Merchant Banking Division to Support Ambitious Growth Plans

Mai 2015

11

Historic decision grants Italian women direct access to ellaOne® oral emergency contraceptive

Avril 2015

17

ellaOne® Receives Prestigious Nicholas Hall & Company Award for the Most Innovative European New Product of the Year

HRA Pharma Closes Investment in Embera NeuroTherapeutics to Advance Development of Novel Therapies for Addiction

Avril 2015

12

HRA Pharma Closes Investment in Embera NeuroTherapeutics to Advance Development of Novel Therapies for Addiction

Avril 2015

10

Emergency contraceptive pill roll out across Europe brings prescription-free ellaOne® to millions of women

filtrer par
SANTE DE LA FEMME
ENDOCRINOLOGIE
Thérapie cellulaire
CORPORATE
REGLEMENTAIRE
fermerVous êtes sur le point de quitter hra pharma
Vous êtes sur le point de quitter www.hra-pharma.com et d’être redirigé vers un site externe qui pourrait ne pas être sous le contrôle de HRA Pharma..
voulez-vous continuer ?